Work

Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-d-arabinofuranosyluracil (FMAU) in tumor-bearing rats

Year: 2004

Type: article

Source: Nuclear Medicine and Biology

DOI: 10.1016/j.nucmedbio.2004.01.001

Authors: James R. Bading, Antranik H. Shahinian, Amy Vail, Pravin Bathija, G.W. Koszalka, Robert T. Koda, Mian M. Alauddin, John D. Fissekis, Peter S. Conti

Institutions: University of Southern California, GlaxoSmithKline (United States)

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G4222874576, IN VIVO MARKER OF CELL PROLIFERATION FOR PET STUDIES

OpenAlex ID: W2140693138

FWCI: 3.061

Cites: 44

Cited by: 35

Related to: 10